{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-068406","form_type":"8-K","ticker":"ACAD","cik":"0001070494","company_name":"ACADIA PHARMACEUTICALS INC","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.773994+00:00","generated_at":"2026-06-18T04:11:21.003668+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Acadia discloses $9.2M total exposure to failed Silicon Valley Bank","bullets":["Approximately $1M in deposit accounts at SVB for daily cash needs as of March 10, 2023.","Approximately $5.8M in restricted cash in money-market accounts as collateral for office leases and corporate charge card.","Approximately $2.4M in receivables in a lockbox account at SVB.","Company states exposure to SVB is limited; total disclosed exposure about $9.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-068406","json":"https://secwatch.observer/filing/0001193125-23-068406.json","markdown":"https://secwatch.observer/filing/0001193125-23-068406.md","text":"https://secwatch.observer/filing/0001193125-23-068406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070494/000119312523068406/0001193125-23-068406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070494/000119312523068406/d409752d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:11:21.003668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}